References:
  1. Harfouch RM, Moualla YM, Shahoud SM, Belal LA, Mohammad BS, Mustafa NM, Souliman OA, Elshemali YI (2021). Epidemiology of COVID-19 in the most pandemic Countries: A review article. Acad . J. Biotechnol. 9(1): 021-027.
  2. Mehmet Rami Helvaci et al. Positive and negative acute phase reactants in sickle cell diseases. World Family Medicine. 2022; 20(3): 43-51. DOI: 10.5742/MEWFM.2022.95250
  3. Harfouch RM, Alshaikh S, Alshimaly M, Assaad A, Ahmad J, Zoughaibi H, Hammadi M, Elshimali Y. Therapeutic approaches for COVID 19: Challenges and successes. Ann Clin Anal Med. 2020.
  4. Cron, R.Q., Caricchio, R. & Chatham, W.W. Calming the cytokine storm in COVID-19. Nat Med 27, 1674–1675 (2021). https://doi.org/10.1038/s41591-021-01500-9.
  5. Shimizu M. Clinical Features of Cytokine Storm Syndrome. In: Cron RQ, Behrens EM, eds. Cytokine Storm Syndrome. Cham, Springer International Publishing, 2019; pp. 31–41.
  6. Chen LYC, Hoiland RL, Stukas S, Wellington CL, Sekhon MS. Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome. Eur Respir J. 2020;56(4):2003006. Published 2020 Oct 1. doi:10.1183/13993003.03006-2020
  7. Harfouch RM. Cytokine Storm Syndrome in Covid-19 Patients: Characteristics and Diagnosis. Journal of Clinical Epidemiology & Toxicology. SRC/JCET-131. DOI: doi. org/10.47363/JCET/2021 (2). 2021;121:2-3.
  8. Mokhtari T, Hassani F, Ghaffari N, Ebrahimi B, Yarahmadi A, Hassanzadeh G. COVID-19 and multiorgan failure: A narrative review on potential mechanisms. J Mol Histol. 2020 Dec;51(6):613-628. doi: 10.1007/s10735-020-09915-3. Epub 2020 Oct 4. PMID: 33011887; PMCID: PMC7533045.
  9. Yao XH, Li TY et al. A pathological report of three COVID-19 cases by minimally invasive autopsies. Chin. J. Pathol 2020; 49: E009.
  10. Alhouri A, Salloum A, Harfouch RM, Soumya G. Possible Side Effects of using Detergents during the Covid19 Pandemic in Syria. Ann Clin Cases. 2020;1(4):1023.
  11. Murakami M, Kamimura D, Hirano T. Pleiotropy and specificity: insights from the interleukin 6 family of cytokines. Immunity 2019; 50: 812–31.
  12. Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506.
  13. Harfouch RM (2022) Antiviral Effects of Propolis against SARS-COV 2. Int J Clin Med Imaging 9:809.
  14. Tang Y, Liu J, Zhang D, Xu Z, Ji J and Wen C (2020) Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies. Front. Immunol. 11:1708. doi: 10.3389/fimmu.2020.01708